The Future of Cancer Treatment Looks Bright
Over the last few months, more than $30 billion has been invested in biotechnology companies to spur research and development, particularly in the area of cancer treatments. Companies like Global Cancer Technology are developing innovative treatments in an effort to one day halt the progression of deadly diseases like glioblastoma.
Why are Cancer Patients Skipping Their Treatments?
Cancer patients have been skipping their treatments since the pandemic began. In some cases, clinics have temporarily closed their facilities or halted their procedures due to the outbreak; in other cases, patients have been afraid of contracting the virus.
Imagion to develop nanocrystals for treating breast cancer
Early cancer detection specialist Imagion Biosystems Limited (ASX: IBX) has entered into a Joint…
Biotech Daily (newsletter) – Imagion, GCT work on nano-scintillator for breast cancer
Thursday August 12, 2021 Daily news on ASX-listed biotechnology companies * AS X FLAT, BIOTECH…
Imagion Biosystems (ASX:IBX) up on deal to develop breast cancer treatment
Shares of Imagion Biosystems (ASX:IBX) jumped as much as 9% to AU$0.085, their highest since…
Imagion Biosystems Enters Agreement to Develop Nanocrystals for Treating Breast Cancer
Imagion Biosystems is pleased to announce it has entered into a Joint Development Agreement…
Phoenix and Maricopa County Proclaim July 21st as Glioblastoma Awareness Day
PHOENIX, July 21, 2021 /PRNewswire/ — In recognition of the local strides being made in the…
San Diego company aiming to target glioblastoma with nanotechnology-based approach
The emerging biopharmaceutical company Global Cancer Technology (GCT; San Diego) is…
Global Cancer Technology Appoints Chief Scientific Consultant and Advisor
GCT strengthens science development team with top appointment of biotech and…
BioSpace Movers & Shakers
Biopharma and life sciences organizations strengthen their leadership teams and board with…
What Will It Take to Bring Glioblastoma Research to the Forefront?
Dr. Loralyn Mears is the Director of Scientific Communications for Global Cancer Technology, and..
Global Cancer Technology to raise $9M through a Reg A+ offering to fund potential COVID treatment
Global Cancer Technology Inc CEO John Clark tells Proactive the privately-held biopharmaceutical…